title: [Use of oral fluid metabolic rates for the assessment of reparative osteogenesis after bone augmentation procedures].
abstract: The use of osteoplastic materials allows extending indications for dental implants placement by considerable alveolar bone atrophy. The aim of the study was to reveal bone tissue metabolites which can be used as early bone destruction markers after bone augmentation procedure before any radiological signs occur. For this purpose the content of osteocalcinum, C-telopeptides, alkaline phosphatase and lactate dehydrogenase was examined in oral fluid. The increase of osteocalcinum and C-telopeptides and decrease activity of alkaline phosphatase and lactate dehydrogenase in comparison with control represented the pattern specific for bone destruction.
authors.forename: E S
authors.initials: ES
authors.lastname: Golovina
authors.forename: F N
authors.initials: FN
authors.lastname: Gil'miiarova
authors.forename: V P
authors.initials: VP
authors.lastname: Tlustenko
mesh_terms: D000328:Adult; D000469:Alkaline Phosphatase / Q000032:analysis / Q000378:metabolism; D000540:Alveolar Ridge Augmentation; D001861:Bone Regeneration; D024042:Collagen Type I / Q000032:analysis / Q000378:metabolism; D005260:Female; D006801:Humans; D007770:L-Lactate Dehydrogenase / Q000032:analysis / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D015675:Osteocalcin / Q000032:analysis / Q000378:metabolism; D010012:Osteogenesis; D010455:Peptides / Q000032:analysis / Q000378:metabolism; D012463:Saliva / Q000737:chemistry / Q000378:metabolism*
chemical_list: D024042:Collagen Type I; D010455:Peptides; C052929:collagen type I trimeric cross-linked peptide; D015675:Osteocalcin; D007770:L-Lactate Dehydrogenase; D000469:Alkaline Phosphatase